[Antineutrophil cytoplasmic antibody(ANCA)]

Masaharu Yoshida1

  • 1Department of Nephrology, Hachioji Medical Center of Tokyo Medical University, Hachioji 193-0998.

Rinsho Byori. the Japanese Journal of Clinical Pathology
|August 20, 2003
PubMed

Insights

Anti-neutrophil cytoplasmic antibody (ANCA) vasculitis involves specific antibodies. Detecting myeloperoxidase (MPO)-ANCA and proteinase-3 (PR-3)-ANCA with ELISA improves diagnosis and monitoring of ANCA-associated vasculitis.

Area of Science:

  • Immunology
  • Rheumatology
  • Clinical Chemistry

Context:

  • Anti-neutrophil cytoplasmic antibodies (ANCA) are key diagnostic markers for small vessel vasculitis.
  • Two main subtypes, myeloperoxidase (MPO)-ANCA and proteinase-3 (PR-3)-ANCA, exhibit distinct immunofluorescence patterns.
  • PR-3 ANCA is highly specific for Wegener's granulomatosis (WG), while MPO-ANCA is more prevalent in microscopic polyangiitis (MPA) and other conditions.

Purpose:

  • To evaluate the diagnostic and monitoring utility of antigen-specific ELISA for MPO-ANCA and PR-3 ANCA.
  • To correlate ANCA titers with disease activity in ANCA-associated vasculitis (AAV).
  • To assess the clinical manifestations and treatment efficacy in AAV.

Summary:

  • Indirect immunofluorescence (IIF) for ANCA detection is enhanced by standardized antigen-specific ELISA.
  • ELISA demonstrated low intra-assay and inter-assay coefficients of variation (CV) for MPO and PR-3.
  • A strong correlation was observed between MPO-ANCA ELISA titers and AAV disease activity.
  • Renal and pulmonary manifestations are common initial symptoms in 70-90% of AAV patients.
  • ANCA titer changes reflect disease activity in 60-70% of AAV patients.
  • Combination therapy with steroids and immunosuppressants effectively manages AAV symptoms.

Impact:

  • Standardized ELISA assays improve the accuracy and reliability of ANCA testing.
  • Correlating ANCA titers with disease activity allows for more precise patient management and treatment adjustments.
  • This approach aids in early diagnosis and monitoring of AAV, potentially improving patient outcomes.
  • Understanding the prevalence of MPO-ANCA and PR-3 ANCA in different vasculitis subtypes refines diagnostic criteria.